Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Not applicableUnknownNCT04428346
What this trial is testing

A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 400
Not applicableUnknownNCT06104046
What this trial is testing

Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

Who this might be right for
Hepatitis C Virus
Assiut University 50
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Not applicableStudy completedNCT04525690
What this trial is testing

Improving Inpatient Screening for Hepatitis C

Who this might be right for
Hepatitis C
University of Pennsylvania 7,634
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Not applicableStudy completedNCT04268173
What this trial is testing

Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3

Who this might be right for
Drug Use DisordersHepatitis CHarm Reduction+1 more
University of Wisconsin, Madison 343
Not applicableLooking for participantsNCT05870969
What this trial is testing

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Who this might be right for
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2 more
Ruijin Hospital 20,000
Not applicableStudy completedNCT04008927
What this trial is testing

A Community-based Intervention Among Active Drug Users in Montpellier

Who this might be right for
Drug UseHCV Infection
ANRS, Emerging Infectious Diseases 554
Not applicableUnknownNCT03420573
What this trial is testing

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

Who this might be right for
Parkinson Disease
Kasr El Aini Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00423670
What this trial is testing

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 765
Early research (Phase 1)WithdrawnNCT00947245
What this trial is testing

Japanese Bridging Study Conducted in the United States

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb
Not applicableUnknownNCT02657694
What this trial is testing

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

Who this might be right for
Hepatitis C
FixHepC 10,000
Testing effectiveness (Phase 2)WithdrawnNCT00930995
What this trial is testing

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Kaiser Permanente
Large-scale testing (Phase 3)UnknownNCT03540212
What this trial is testing

Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus

Who this might be right for
Chronic HCV Infection
Ain Shams University 50
Large-scale testing (Phase 3)Study completedNCT02023112
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
AbbVie 171
Large-scale testing (Phase 3)Study completedNCT03080415
What this trial is testing

Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir

Who this might be right for
Hepatitis C Genotype 4
Yassin Abdelghaffar Charity Center for Liver Disease and Research 40
Testing effectiveness (Phase 2)Study completedNCT00851890
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 30
Not applicableStudy completedNCT01159613
What this trial is testing

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Who this might be right for
Chronic Hepatitis C Viral Infection
Ziv Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Next Page